Back
Royal Caribbean Group Vs. Corcept Therapeutics Industry Stock Comparison
Buy
87
RCL
Royal Caribbean Group
Last Price:
225.16
Seasonality Move:
5.55%
Buy
87
CORT
Corcept Therapeutics
Last Price:
59.57
Seasonality Move:
3.97%
Buy
87
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $225.27. The Score for RCL is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $225.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.73 | Buy |
| Relative Strength Index (14 RSI): | 71.9 | Buy |
| Chaikin Money Flow: | 352359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.63 - 213.55) | Buy |
| Bollinger Bands (100): | (152.09 - 191.77) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.95 | Buy |
| Relative Strength Index (14 RSI): | 80.63 | Buy |
| Chaikin Money Flow: | 759215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.11 - 51.89) | Buy |
| Bollinger Bands (100): | (31.7 - 45.68) | Buy |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 213.05 | Buy |
| 20-day SMA: | 206.15 | Buy |
| 50-day SMA: | 185.5 | Buy |
| 200-day SMA: | 153.26 | Buy |
| 8-day EMA: | 215.37 | Buy |
| 20-day EMA: | 205.89 | Buy |
| 50-day EMA: | 190.47 | Buy |
| 200-day EMA: | 157.06 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.72 | Buy |
| 20-day SMA: | 49.28 | Buy |
| 50-day SMA: | 44.07 | Buy |
| 200-day SMA: | 32 | Buy |
| 8-day EMA: | 53.06 | Buy |
| 20-day EMA: | 49.83 | Buy |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 35.31 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.04 per share, and an increase next year of $2.67 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Royal Caribbean Group Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||